The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the histamine H3 receptor (Ia). Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders.
本发明涉及公式(Ia)的化合物及其药学上可接受的盐、溶剂和
水合物,该化合物调节
组胺H3受体(Ia)的活性。本发明的化合物及其制药组合物适用于治疗
组胺H3相关疾病的方法。